Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the first quarter ended March 31, 2026.

The 56-location Georgia-based retailer plans to reinvest proceeds from the divestment into growing its convenience store banner.

Total revenue of $140 million in the first quarter of 2026 Pfizer agreement announced in January for non-exclusive license to utilize Matrix-M® in two infectious ...

Novavax ended the first quarter of 2026, with $818 million in cash and accounts receivables. We added $80 million of nondilutive cash in the first quarter of 2026, including a $30 million Pfizer ...

Novavax (NVAX) shares added ~6% in the premarket on Wednesday after the COVID-19 vaccine maker well exceeded Street forecasts with its Q1 financials, thanks to a licensing deal with Pfizer (PFE) ...

The U.S. Marine Corps (USMC) has selected the R66 TURBINETRUCK and an autonomous Bell 505 as finalists for a program aimed at ...

Explore how the CSAI Foundation is securing autonomous AI agents with new frameworks, certifications, and global assurance ...

Month Phase 2 data in High-Risk NMIBC to be presented Friday, May 15, 2026Phase 3 overview to be presented at Trials-in-Progress session on ...

Carolina Panthers running back Jonathon Brooks has been cleared to participate in the team’s offseason conditioning program.

The stars and your medical records When NASA’s Artemis II crew hurtled back to Earth from their ten-day mission, the four ...

U.S. Rep. Keith Self explains his votes and tells us whether he supports a blank check for the Iran War.